BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34210495)

  • 21. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
    Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
    BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare germline mutations in African American men diagnosed with early-onset prostate cancer.
    Beebe-Dimmer JL; Zuhlke KA; Johnson AM; Liesman D; Cooney KA
    Prostate; 2018 Apr; 78(5):321-326. PubMed ID: 29356034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
    Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
    Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repair-Gene Mutations Uncovered in Metastatic Prostate Cancer.
    Cancer Discov; 2016 Sep; 6(9):OF3. PubMed ID: 27460689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
    Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.
    Donald N; Malik S; McGuire JL; Monahan KJ
    Fam Cancer; 2018 Jan; 17(1):43-52. PubMed ID: 28508326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
    Dow E; Buchanan DD; Winship IM
    Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Stolarova L; Kleiblova P; Janatova M; Soukupova J; Zemankova P; Macurek L; Kleibl Z
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
    Carwana H; Hoodfar E; Bergoffen J; Li D
    Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
    Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
    Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate Cancer Predisposition.
    Bhanji Y; Isaacs WB; Xu J; Cooney KA
    Urol Clin North Am; 2021 Aug; 48(3):283-296. PubMed ID: 34210485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.
    Nieminen TT; O'Donohue MF; Wu Y; Lohi H; Scherer SW; Paterson AD; Ellonen P; Abdel-Rahman WM; Valo S; Mecklin JP; Järvinen HJ; Gleizes PE; Peltomäki P
    Gastroenterology; 2014 Sep; 147(3):595-598.e5. PubMed ID: 24941021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer].
    Matveev VB; Kirichek AA; Filippova MG; Savinkova AV; Khalmurzaev OA; Lyubchenko LN
    Urologiia; 2019 Dec; (5):79-85. PubMed ID: 31808637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Lynch Syndrome.
    Maratt JK; Stoffel E
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
    Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline genetics of prostate cancer.
    Khan HM; Cheng HH
    Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S3-S12. PubMed ID: 35657157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53.
    Lee BH
    Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.